SAHPA1-VHLL

General Information


DRACP ID  DRACP05935

Peptide Name   SAHPA1-VHLL

Sequence  PQRⓍILDQHVⓍRVMKXALAPYIP

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides β-catenin degrader



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  β-catenin

Affinity  Not available

Mechanism  Inhibit wnt/β-catenin signaling pathway

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(3) and Ⓧ (10) are cross-linked by hydrocarbon stapling

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  Ⓧ(3)=R8; Ⓧ(10)=(S)-2-(4'-pentenyl)alanine

Chiral  L



Physicochemical Information


Formula  C107H171N31O23S

Absent amino acids  CEFGNSTW

Common amino acids  P

Mass  279439

Pl  10.45

Basic residues  4

Acidic residues  1

Hydrophobic residues  8

Net charge  3

Boman Index  -2626

Hydrophobicity  -9.57

Aliphatic Index  101.74

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  67.73

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32550000

Title  A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer

Doi 10.1038/s41421-020-0171-1

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.